Health Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Albireo
Albireo Appoints Dr Hans Graffner as Chief Medical Officer
May 30th, 2008
Albireo, a pharmaceutical company focusing on the development of therapeutics for gastrointestinal diseases, announced the appointment of Hans Graffner, M.D., Ph.D, as Chief Medical Officer (CMO). Dr. Graffner will oversee the clinical development programs at Albireo with initial focus on the lead program A3309, a therapeutic with a novel mechanism of action targeting the treatment of patients with chronic constipation. Dr. Graffner comes to Albireo with over 12 years experience of leading clinical development programs in the pharmaceutical industry. Most recently, Dr. Graffner was the Senior Medical Director at Merck Serono, leading clinical...
Source: Health Business Week (2008-05-30)
|
